Insys Therapeutics, Inc. – Trademark Portfolio

Entity Type: 03

Insys Therapeutics, Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SYNDROS and INSYS THERAPEUTICS, INC.. The owner is based in Chandler, AZ.

Suite 100

1333 South Spectrum Blvd

Chandler, AZ 85286

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Insys Therapeutics, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (10 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Insys Therapeutics, Inc. have?

Insys Therapeutics, Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 2 registered, 7 abandoned, 2 cancelled.

What trademark classes does Insys Therapeutics, Inc. file in?

Insys Therapeutics, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Insys Therapeutics, Inc.'s most well-known trademarks?

Insys Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as SYNDROS and INSYS THERAPEUTICS, INC.. These are among 2 currently registered trademarks in the portfolio.

What is Insys Therapeutics, Inc.'s trademark registration success rate?

Insys Therapeutics, Inc. has a 18% trademark registration rate, with 2 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.